Search Within

Michal Sternschuss

Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
  3. Review (1)
Groups
  1. Department of Medicine (10)
  2. Genitourinary Oncology Service (10)
  3. Solid Tumor Oncology Division (10)
  4. Epidemiology and Biostatistics (7)
  5. GME, Medicine (7)
  6. Graduate Medical Education (7)

More Groups

People
  1. Jonathan Rosenberg (9)
  2. David Aggen (7)
  3. Gopakumar Iyer (7)
  4. Samuel Funt (7)
  5. Dean Bajorin (6)
  6. Irina Ostrovnaya (6)

More People

Years
  1. 2025 (7)
  2. 2024 (3)
Publications
  1. Journal of Clinical Oncology (5)
  2. Annals of Oncology (1)
  3. ESMO Open (1)
  4. Future Oncology (1)
  5. JCO Oncology Practice (1)
  6. Laboratory Investigation (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. European Society for Medical Oncology (1)
  3. Future Medicine (1)
  4. Nature Publishing Group (1)
  5. Oxford University Press (1)

Results (10)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cutaneous toxicity and clinical outcomes with enfortumab vedotin and pembrolizumab in patients with locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Arbuiso, A.; Sternschuss, M.; Whiting, K.; Gupta, A.; Huttenlocher Bent, E.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Treatment patterns and clinical outcomes with platinum-based chemotherapy after enfortumab vedotin and pembrolizumab in patients with metastatic urothelial carcinoma
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Arbuiso, A.; Gupta, A.; Bent, E. H.; Alvarez, N.; Regazzi, A. M.; Liang, S.; Ahmed, F.; Akin, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Quality of informed consent via telemedicine compared with in-person for clinical cancer research
    Journal Article

    Sternschuss, M.; Lattanzi, M.; Vertosick, E.; Austria, M.; Martin, S.; Regazzi, A.; Buckely, M. T.; Lengfellner, J.; Riely, G. J.; Solit, D. B.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma
    Journal Article

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N. M.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • Enfortumab vedotin and pembrolizumab: Redefining the standard of care for previously untreated advanced urothelial cancer
    Review

    Sternschuss, M.; Rosenberg, J. E.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • DNA damage repair alterations as predictive biomarker for platinum-based chemotherapy in metastatic urothelial cancer
    Meeting Abstract

    Sternschuss, M.; Paynter, A.; Xu, W. X.; Nichols, C.; Hoppe, J.; Davis, N. B.; Jiang, D. M.; Shah, N. J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Correlation of NECTIN4 amplification and expression with response to enfortumab vedotin (EV) treatment in locally advanced or metastatic urothelial carcinoma
    Meeting Abstract

    Yol, C.; Irawan, H.; Sternschuss, M.; Gupta, A.; Bent, E.; Basar, M.; Chen, J. F.; Sarungbam, J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Teo, M. Y.; Bajorin, D.; Kotecha, R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results
    Meeting Abstract

    Sternschuss, M.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Goh, A. C.; Cha, E. K.; Donat, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of sacituzumab govitecan (SG) after prior exposure to enfortumab vedotin (EV) in patients with metastatic urothelial carcinoma (mUC)
    Meeting Abstract

    Sternschuss, M.; Toumbacaris, N.; Das, J. P.; Powles, T.; Bajorin, D. F.; Kotecha, R. R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save